Veterinary Generics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Veterinary Generics Market: By Product Type (Antibiotics, NSAIDS, Veterinary antifungal drugs, Veterinary antihelminthics, Veterinary biologics),By Animal Type (Small pets, (Canine, Feline) Swine, Bovine, Horses, Others), By End Users (Veterinary Hospitals, Veterinary Clinics),and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global veterinary generics market is anticipated to offer potential growth opportunities for the market players over the forecast period.Rapid evolutions of generic molecules with similar therapeutic activity, the cost-effectiveness of the products are enabling to attract the customers towards the veterinary generics. The active pharmaceutical ingredient (API) of the generic molecule must be bioequivalent to the patented product. Veterinary pharma companies are focused on production generic molecules in order to meet the unmet need in the market. Increased adoption of small animals such as dogs and cats are trending from the past few years. The rise in the prevalence of various diseases like osteoarthritis (OA), chronic cancer pain, inflammation, other skin allergies are expected create demand for veterinary generics market. The generic products have cost less than the branded products, so the cost of the treatment will reduce. This enables greater margin on the farm with same desired effects and ensures good welfare standards. The introduction of generic products able to increase the competition within the market for that active ingredient, less cost of the product making it more affordable to the end user. Increased veterinary hospitals and clinics to offer better services small animals as well as farm animals anticipated to witness significant growth in veterinary generics market. Introduction of new generic drugs to treat chronic and acute pain, inflammation, other diseases are creating healthy growth opportunities. Rise in mergers & acquisitions to offer affordable products,   is able to offer novel analgesics to the market. Increased awareness among the veterinary specialists and introduction of generic drugs are anticipated to create lucrative opportunities over the forecast period.

Veterinary Generics Market

MARKET SUMMARY
-
x%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– x%
  • Largest Market– Europe
  • Fastest Growing Market– North America

Veterinary Generics Market

  • The report on global Veterinary generics market gives historical, current and future market sizes (US$ Mn) based on product, application, animal type, end users and geographical regions.
  • Veterinary generics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Zoetis Inc.,
  • Elanco,
  • Merial,
  • Bayer Animal Health,
  • Virbac S.A.,
  • Ceva Sante Animale,
  • Vetoquinol S.A.
Veterinary Generics Market

Drivers And Restraints

Increasing farm animal and poultry industry across the globe is expected to create the demand for veterinary generics market. Favorable government policies to enhance the farm animal production create awareness about various diseases and treatment methods are expected to create demand for veterinary market over the forecast period. Furthermore, increased awareness regarding veterinary generic drugs among veterinary professionals is expected to fuel market.


Asia-Pacific got significant share

Veterinary Generics Market

Geographically market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. U.S. veterinary generics market is expected to account for major market share over the forecast time frame due to increased pet adoption and raising awareness among pet lovers regarding the animal health and various treatment options in the country. Europe veterinary generics market is expected witness for robust growth rate over the forecast period. Germany veterinary generics market is anticipated to dominate the regional market share due to increased demand for meat and other protein-rich food. Moreover, increased awareness is creating growth opportunities for the market players. China veterinary generics market is accounted for the major market share in Asia Pacific, due to rising population and increased demand for food are major drivers of the market. India market is expanding at significant CAGR over the forecast period. Rising disposable income coupled with rising veterinary healthcare facilities, increasing adoption of small animals such as cats and dogs are expected to accelerate the market size. Latin America veterinary generics market is led by Brazil, is witnessing to grow at unprecedented CAGR over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In January 2017, Elanco launched Galliprant (Grapriprant tablets) for treatment of management of pain and inflammation associated with canine osteoarthritis.

Key

Report Outline

Veterinary Generics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

1. Executive Summary
2. Global Veterinary Generics Market Introduction
2.1. Global Veterinary Generics Market – Taxonomy
2.2. Global Veterinary Generics Market –Definitions
2.2.1. Product Type
2.2.2. Animal Type
2.2.3. End User
3. Global Veterinary Generics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Veterinary Generics Market Dynamic Factors – Impact Analysis
3.6. Global Veterinary Generics Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Veterinary Generics Market – Recent Product Introductions
4. Global Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Veterinary Generics Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026
5.1. Antibiotics
5.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. NSAIDS
5.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Veterinary Antifungal Drugs
5.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Veterinary Anthelminthic
5.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Veterinary Biologics
5.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Veterinary Generics Market Forecast, By Animal Type, 2015 – 2019 and Forecast, 2020 – 2026
6.1. Small Pets
6.1.1. Canine
6.1.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.1.3. Market Opportunity Analysis
6.1.2. Feline
6.1.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.2.3. Market Opportunity Analysis
6.2. Swine
6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Bovine
6.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Horses
6.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Veterinary Generics Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Veterinary Clinics
7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Veterinary Generics Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026
8.1. North America
8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Veterinary Generics Market – Opportunity Analysis Index, By Product Type, By Animal Type, By End User and Region, 2020 – 2026
9. North America Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
9.1. Drug Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Antibiotics
9.1.2. NSAIDS
9.1.3. Veterinary Antifungal Drugs
9.1.4. Veterinary Anthelmentic
9.1.5. VeterinaryBiologics
9.2. Animal Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Small Pets
9.2.1.1. Canine
9.2.1.2. Feline
9.2.2. Swine
9.2.3. Bovine
9.2.4. Horses
9.2.5. Others
9.3. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.4. Country Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. U.S.
9.4.2. Canada
9.5. North America Veterinary Generics Market – Opportunity Analysis Index, , By Product Type, By Animal Type, By End User and Country, 2020 – 2026
9.6. North America Veterinary Generics Market Dynamics – Trends
10. Europe Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
10.1. Drug Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Antibiotics
10.1.2. NSAIDS
10.1.3. Veterinary Antifungal Drugs
10.1.4. Veterinary Anthelmentic
10.1.5. VeterinaryBiologics
10.2. Animal Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Small Pets
10.2.1.1. Canine
10.2.1.2. Feline
10.2.2. Swine
10.2.3. Bovine
10.2.4. Horses
10.2.5. Others
10.3. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.4. Country Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Russia
10.4.7. Poland
10.4.8. Rest of Europe
10.5. Europe Veterinary Generics Market – Opportunity Analysis Index, , By Product Type, By Animal Type, By End User and Country, 2020 – 2026
10.6. Europe Veterinary Generics Market Dynamics – Trends
11. Asia-Pacific Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
11.1. Drug Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Antibiotics
11.1.2. NSAIDS
11.1.3. Veterinary Antifungal Drugs
11.1.4. Veterinary Anthelmentic
11.1.5. VeterinaryBiologics
11.2. Animal Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Small Pets
11.2.1.1. Canine
11.2.1.2. Feline
11.2.2. Swine
11.2.3. Bovine
11.2.4. Horses
11.2.5. Others
11.3. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Veterinary Hospitals
11.3.2. Veterinary Clinics
11.4. Country Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Veterinary Generics Market – Opportunity Analysis Index, , By Product Type, By Animal Type, By End User and Country, 2020 – 2026
11.6. Asia-Pacific Veterinary Generics Market Dynamics – Trends
12. Latin America Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
12.1. Drug Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Antibiotics
12.1.2. NSAIDS
12.1.3. Veterinary Antifungal Drugs
12.1.4. Veterinary Anthelmentic
12.1.5. VeterinaryBiologics
12.2. Animal Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Small Pets
12.2.1.1. Canine
12.2.1.2. Feline
12.2.2. Swine
12.2.3. Bovine
12.2.4. Horses
12.2.5. Others
12.3. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Veterinary Hospitals
12.3.2. Veterinary Clinics
12.4. Country Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Venezuela
12.4.5. Rest of Latin America
12.5. Latin America Veterinary Generics Market – Opportunity Analysis Index, , By Product Type, By Animal Type, By End User and Country, 2020 – 2026
12.6. Latin America Veterinary Generics Market Dynamics – Trends
13. Middle East and Africa Veterinary Generics Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
13.1. Drug Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Antibiotics
13.1.2. NSAIDS
13.1.3. Veterinary Antifungal Drugs
13.1.4. Veterinary Anthelmentic
13.1.5. VeterinaryBiologics
13.2. Animal Type Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Small Pets
13.2.1.1. Canine
13.2.1.2. Feline
13.2.2. Swine
13.2.3. Bovine
13.2.4. Horses
13.2.5. Others
13.3. Distribution Channel Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Veterinary Hospitals
13.3.2. Veterinary Clinics
13.4. Country Analysis 2019 and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Veterinary Generics Market – Opportunity Analysis Index, , By Product Type, By Animal Type, By End User and Country, 2020 – 2026
13.6. MEA Veterinary Generics Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Zoetis Inc.
14.2.2. Elanco
14.2.3. Merial
14.2.4. Bayer Animal Health
14.2.5. Virbac S.A.
14.2.6. IDEXX Laboratories
14.2.7. Boehringer Ingelheim Vetmedica
14.2.8. Ceva Sante Animale
14.2.9. Vetoquinol S.A.
15. Research Methodology
16. Key Assumptions and Acronyms


Report

Company Profile

  •  Zoetis Inc.
  • Elanco
  • Merial
  • Bayer Animal Health
  • Virbac S.A.
  • IDEXX Laboratories
  • Boehringer Ingelheim Vetmedica
  • Ceva Sante Animale
  • Vetoquinol S.A.

Description

Global veterinary generics market is anticipated to offer potential growth opportunities for the market players over the forecast period.Rapid evolutions of generic molecules with similar therapeutic activity, the cost-effectiveness of the products are enabling to attract the customers towards the veterinary generics. The active pharmaceutical ingredient (API) of the generic molecule must be bioequivalent to the patented product. Veterinary pharma companies are focused on production generic molecules in order to meet the unmet need in the market. Increased adoption of small animals such as dogs and cats are trending from the past few years. The rise in the prevalence of various diseases like osteoarthritis (OA), chronic cancer pain, inflammation, other skin allergies are expected create demand for veterinary generics market. The generic products have cost less than the branded products, so the cost of the treatment will reduce. This enables greater margin on the farm with same desired effects and ensures good welfare standards. The introduction of generic products able to increase the competition within the market for that active ingredient, less cost of the product making it more affordable to the end user. Increased veterinary hospitals and clinics to offer better services small animals as well as farm animals anticipated to witness significant growth in veterinary generics market. Introduction of new generic drugs to treat chronic and acute pain, inflammation, other diseases are creating healthy growth opportunities. Rise in mergers & acquisitions to offer affordable products,   is able to offer novel analgesics to the market. Increased awareness among the veterinary specialists and introduction of generic drugs are anticipated to create lucrative opportunities over the forecast period.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX